Non-Operating Income/Expense (Quarterly)

Non-Operating Income/Expense: The sum of all non-operating expenses for the given industry.

MiMedx Group, Inc (MDXG) had Non-Operating Income/Expense of $0.66M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$113.72M
Net Income	$16.75M
Cost of Goods Sold	$18.72M
Gross Profit	$95.01M
Operating Expenses	$91.53M
Operating Income	$22.19M
Non-Operating Income/Expense	$0.66M
Pre-Tax Income	$22.85M
Normalized Pre-Tax Income	$22.85M
Income after Taxes	$16.75M
Income from Continuous Operations	$16.75M
Consolidated Net Income/Loss	$16.75M
Normalized Income after Taxes	$16.75M
EBIT	$22.19M
EBITDA	$27.48M
Weighted-Average Shares Outstanding (Basic)	148.04M
Weighted-Average Shares Outstanding (Diluted)	149.71M
Earnings per Share (EPS) (Basic)	$0.11
Earnings per Share (EPS) (Diluted)	$0.11
Balance Sheet Financials
Current Assets	$254.09M
Property, Plant, and Equipment	$5.00M
Long-Term Assets	$64.89M
Total Assets	$318.99M
Current Liabilities	$57.68M
Long-Term Debt	$16.84M
Long-Term Liabilities	$22.36M
Total Liabilities	$80.04M
Common Equity	$238.95M
Tangible Shareholders Equity	$208.36M
Shareholders Equity	$238.95M
Common Shares Outstanding	148.08M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$49.05M
Cash Flow from Investing Activities	$-6.55M
Cash Flow from Financial Activities	$-4.83M
Beginning Cash	$104.42M
End Cash	$142.08M
Increase/Decrease in Cash	$37.67M
Stock-Based Compensation	$13.93M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	4.41
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.07
Debt to Equity Ratio	0.08
Gross Margin	83.54%
Operating Margin	19.51%
EBIT Margin	19.51%
EBITDA Margin	--
Pre-Tax Profit Margin	20.09%
Profit Margin	14.73%
Free Cash Flow	$48.26M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.36
Inventory Turnover	0.71
Receiveable Turnover	1.45
Days Sales in Receivables	61.88
Return on Equity	7.01%
Return on Tangible Equity	8.04%
Return on Assets	5.25%
Return on Investments	6.55%
Book Value Per Share	$1.61
Free Cash Flow per Share	$0.32
Operating Cash Flow per Share	$0.33

Data from Zacks Investment Research, Inc.